These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18348513)

  • 1. Recent developments of carbonic anhydrase inhibitors as potential anticancer drugs.
    Thiry A; Supuran CT; Masereel B; Dogné JM
    J Med Chem; 2008 Jun; 51(11):3051-6. PubMed ID: 18348513
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
    Winum JY; Dogné JM; Casini A; de Leval X; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    J Med Chem; 2005 Mar; 48(6):2121-5. PubMed ID: 15771455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives.
    Ahlskog JK; Dumelin CE; Trüssel S; Mårlind J; Neri D
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4851-6. PubMed ID: 19615903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting carbonic anhydrase IX activity and expression.
    Mahon BP; Pinard MA; McKenna R
    Molecules; 2015 Jan; 20(2):2323-48. PubMed ID: 25647573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs].
    Guo J; Li FR; Liu Y; Cheng MS
    Yao Xue Xue Bao; 2013 Nov; 48(11):1637-43. PubMed ID: 24475699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent Silica Nanoparticles with Multivalent Inhibitory Effects towards Carbonic Anhydrases.
    Touisni N; Kanfar N; Ulrich S; Dumy P; Supuran CT; Mehdi A; Winum JY
    Chemistry; 2015 Jul; 21(29):10306-9. PubMed ID: 25965260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of small molecule carbonic anhydrase IX inhibitors.
    Supuran CT
    BJU Int; 2008 Jun; 101 Suppl 4():39-40. PubMed ID: 18430122
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of carbonic anhydrase IX: a new strategy against cancer.
    Winum JY; Scozzafava A; Montero JL; Supuran CT
    Anticancer Agents Med Chem; 2009 Jul; 9(6):693-702. PubMed ID: 19601749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Expression and Crystallization System of Cancer-Associated Carbonic Anhydrase Isoform IX.
    Leitans J; Kazaks A; Balode A; Ivanova J; Zalubovskis R; Supuran CT; Tars K
    J Med Chem; 2015 Nov; 58(22):9004-9. PubMed ID: 26522624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
    D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
    J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential in vitro inhibitory effects of anticancer drugs on tumor-associated carbonic anhydrase isozymes CA IX and CA XII.
    Ozensoy Guler O; Arslan O; Kockar F
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):335-40. PubMed ID: 18806891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
    Supuran CT; Winum JY
    Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides incorporating disulfide bonds that target the tumor-associated isoform IX.
    De Simone G; Vitale RM; Di Fiore A; Pedone C; Scozzafava A; Montero JL; Winum JY; Supuran CT
    J Med Chem; 2006 Sep; 49(18):5544-51. PubMed ID: 16942027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.